CP
AMED

Camelot Portfolios’s Amedisys AMED Stock Holding History

Camelot Portfolios’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,802
Closed -$301K – 211
2019
Q4 		$301K Buy
1,802
+201
+13% +$29.9K 0.13% 172
2019
Q3 		$210K Buy
+1,601
New +$208K 0.1% 203
2019
Q2 		– Sell
-2,450
Closed -$302K – 238
2019
Q1 		$302K Hold
2,450
– – 0.13% 186
2018
Q4 		$287K Sell
2,450
-50
-2% -$5.89K 0.13% 166
2018
Q3 		$312K Buy
+2,500
New +$276K 0.14% 158

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Camelot Portfolios's AMED Position: Q1 2020 in Review

Camelot Portfolios sold out of Amedisys (AMED) in Q1 2020, closing a stake of 1,802 shares — an estimated $301K sold.

Camelot Portfolios first reported a position in AMED in Q3 2018 and held it in 5 quarters. The position peaked at $312K in Q3 2018. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

  • Camelot Portfolios reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
  • Camelot Portfolios sold 1,802 Amedisys shares in Q1 2020, an estimated $301K.
  • Camelot Portfolios first reported a position in Amedisys in Q3 2018 and held it in 5 quarters.
  • Camelot Portfolios's Amedisys position peaked at $312K in Q3 2018.
  • 332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Camelot Portfolios's 13F filing for Q1 2020, filed 28 Apr 2020.